Social isolation and predator scent tests alter brain BDNF levels differentially according to gender, in rats and effects of fluoxetine

We compared different stress conditions on brain BDNF levels, in rats exposed to social isolation test (SIT) and predator scent tests (PST). BDNF expression in the frontal cortex, hippocampus, and amygdala was compared, and effects of chronic fluoxetine (FLU) treatment were evaluated. Rats were exposed to SIT and PST for one month. FLU was given (5 mg/kg/day, ip) throughout stress procedures. Controls, stress, and treatment groups were evaluated in elevated plus maze, anxiety scores were calculated. BDNF expression was determined by Western blot. SIT and PST induced anxiety in both sexes, females had greater anxiety scores than males (p

PDF

___

[1] Duman RS. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry. 2002; 3: 306–310.

[2] Duman RS, Monteggia LM. A Neurotrophic Model for Stress-Related Mood Disorders Biol Psychiatry. 2006; 59(12):1116-1127.

[3] Khundakar AA, Zetterström TS. Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain Res. 2006; 1106(1): 12-20.

[4] Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M. Alteration of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003; 54: 70-75.

[5] Smith MA, Makino S, Kvetnansky R, Post RM. Stress alters the express brain derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995; 15: 1768-1777.

[6] Nibuya M, Takahashi M, Russell DS, Duman RS. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett. 1999; 267(2): 81-84.

[7] Roceri M, Cirulli F, Pessina C, Peretto P, Racagni G, Riva MA. Postnatal repeated maternal deprivation produces agedependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry. 2004; 55(7): 708-714.

[8] Kozlovsky N, Matar MA, Kaplan Z, Kotler M, Zohar J, Cohen H. Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int J Neuropsychopharmacol. 2007; 10(6): 741-758.

[9] Taliaz D, Loya A, Gersner R, Haramati S, Chen A, Zangen A. Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci. 2011; 31(12): 4475-4483.

[10] Martinotti G, Sepede G, Brunetti M, Ricci V, Gambi F, Chillemi E, Vellante F, Signorelli M, Pettorruso M, De Risio L, Aguglia E, Angelucci F, Caltagirone C, Di Giannantonio M. BDNF concentration and impulsiveness level in posttraumatic stress disorder. 2015; 30; 229(3): 814-818.

[11] Hashimoto K. Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2015; 265(1): 83-84.

[12] Shirayama Y, Chen AC, Nakagawa S, Russell RS, Duman RS. Brain derived neurotrophic factor produced antidepressant effects in behavioral models of depression. J Neurosci. 2002; 22: 3251-3261.

[13] Siuciak JA, Boylan C, Fritsche M, Altar CA, Lindsay RM. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res. 1996; 710: 11-20.

[14] Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Neurosci 1996; 16: 2365-2372.

[15] Copella AL, Pei Q, Zetterström TSC. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacol. 2003; 44: 903-910.

[16] Duman RS, Malberg J, Nakagawa S, D’Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry. 2000; 48(8): 732-739.

[17] Kang HJ, Adams DH, Simen A, Simen BB, Rajkowska G, Stockmeier CA, Overholser JC, Meltzer HY, Jurjus GJ, Konick LC, Newton SS, Duman RS. Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder. J Neurosci. 2007; 27(48): 13329-13340.

[18] Mendez-David I, Tritschler L, Ali ZE, Damiens MH, Pallardy M, David DJ, Kerdine-Römer S, Gardier AM. Nrf2- signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression. Neurosci Lett. 2015; 597: 121-126.

[19] Carter-Snell C, Hegadoren K. Stress disorders and gender: implications for theory and research. Can J Nurs Res. 2003; 35: 34-55. [20] Kessler R. Epidemiology of women and depression. J Affect Disord. 2003; 74(1): 5-13.

[21] Lin Y, Ter Horst GJ, Wichmann R, Bakker P, Liu A,Li X, Westenbroek C. Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb Cortex. 2009; 19(9): 1978-1989.

[22] Franklin TB, Perrot-Sinal TS. Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. Psychoneuroendocrinology. 2006; 31(1): 38- 48.

[23] Mitic M, Simic I, Djordjevic J, Radojcic MB, Adzic M. Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats. Neuropharmacology. 2013; 70: 100-611.

[24] Leser IN, Wagner S. The effects of acute social isolation on long-term social recognition memory. Neurobiol Learn Mem. 2015; 124: 97-103.

[25] Zlatkovic J, Bernardi RE, Filipovic D. Protective effect of Hsp70i against chronic social isolation stress in the rat hippocampus. J Neural Transm. 2014; 121: 3–14.

[26] Nestler EJ, Barrett M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002; 34: 13-25.

[27] McEwen B. Stress and hippocampus plasticity. Curr Opin Neurobiol. 1999; 5:205-216.

[28] Duman RS, Malberg J, Thome J. Neural Plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999; 46: 1181-1191.

[29] Sapolsky R. Glucocorticoids and atrophy of the human hippocampus. Sci. 1999; 273: 749-750.

[30] Sapolsky R. Depression, antidepressant, and the shrinking hippocampus. Proc Natl Acad Sci USA. 2001; 98: 12320- 12322.

[31] Zohar J, Matar MA, Ifergane G, Kaplan Z, Cohen H. Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effect. Eur Neuropsychopharmacol. 2008; 9: 653-666.

[32] Cohen H, Matar MA., Richter-Levin G, Zohar J. The contribution of an animal model toward uncovering biological risk factors for PTSD. Ann N Y Acad Sci. 2006; 1071: 335–350.

[33] Mazor A, Michael A, Matar A, Kaplan Z, Kozlovsky N, Zohar J, Kaplan Z, Cohen H. Gender-related qualitative differences in baseline and post-stress anxiety Responses are not reflected in the incidence of criterion-based PTSDlike behaviour patterns. World J Biol Psychiatry. 2009; 10: 856–869.

[34] Pellow S, Chopin P, File SE, Briley M. Validation of open-closed arm entries in an elevated plus maze as measure of anxiety in the rat. J Neurosci Methods. 1985; 14(3): 149-167.

[35] Cohen H, Matar MA, Zohar J. Animal Models of Post-Traumatic Stress. Preclinical Models of Neurologic and Psychiatric Disorders. Curr Protoc Neurosci. 2013; 9(45 Suppl 64):1-18.

[36] Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6nd ed. London:Academic Press, 1986.

[37] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1): 265-275.